Studies Point Way to Precision Therapies for Common Genetic Disorders

News   Feb 10, 2017 | Original story from Princeton University, Engineering School

 
Studies Point Way to Precision Therapies for Common Genetic Disorders

The researchers include: (from left) Trudi Schüpbach, the Henry Fairfield Osborn Professor of Biology; Rebecca Burdine, associate professor of molecular biology; Stanislav Shvartsman, Professor of Chemical and Biological Engineering and the Lewis Sigler Institute for Integrative Genomics; and Yogesh Goyal and Granton Jindal, graduate students in chemical and biological engineering.

 
 
 

RELATED ARTICLES

Magnetized Wire Could be used to Detect Cancer in People

News

Scientists at Stanford used the wire to capture free-floating tumor cells in the blood, a technique that soon could be used in humans to yield an earlier cancer diagnosis.

READ MORE

Key Ingredient in Diabetes Drug Modified to Improve Side Effects

News

Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.

READ MORE

Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein Target

News

A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy